This course has expired. View available courses.
Medication, Medication Management
The Role of Pharmacoeconomics in Decision Making at the Institutional Level for Speciality Drugs (CAN)
Pharmacoeconomics have been used in various ways, including at the institutional level and for formulary decision-making around specialty pharmaceuticals. This program reviews the role of pharmacoeconomics and cost-effectiveness thresholds, along with mechanisms that influence and affect drug policy listing decisions.
DURATION
20 min
PROFESSION
Pharmacy
# OF CREDITS
0.5
ACCREDITATION
CCCEP
EXPIRY DATE
2024-03-10
Pharmacoeconomics have been used in various ways, including at the institutional level and for formulary decision-making around specialty pharmaceuticals. This program reviews the role of pharmacoeconomics and cost-effectiveness thresholds, along with mechanisms that influence and affect drug policy listing decisions.
This program is supported by Pharmascience
Faculty
Ahmad Abulaban, MBBS, SBN, CRND, MSCS, ABCN (CCEEG)
Assistant Professor of Neurology
King Saud bin-Abdulaziz University for Health Sciences
Neurology Consultant
Division of Neurology, Department of Medicine
King Abdulaziz Medical City, National Guard Health Affairs
Yaser M. Al Malik, MD, FRCPC, American Board of Psychiatry and Neurology, CSCN (EEG & EMG)
Assistant professor and Consultant Neurologist
King Saud bin Abdulaziz University for Health Sciences
King Abdulaziz Medical City, Ministry of National Guard Health Affairs
Moe Abdallah, B.SC., B.SC.PHM., R.PH
Clinical pharmacist, Drug Programs Policy and Strategy Branch
Ontario Public Drug Programs
Ministry of Health and Long-Term Care
Michael Boivin, RPh, BScPhm
Clinical Pharmacist Consultant and Continuing Education Developer
Learning objectives
After viewing this expert brief, participants will be better able to:
- Describe how pharmacoeconomics is used to make listing decisions at the hospital /institutional level
- Explain how cost-effectiveness thresholds inform drug policy listing decisions
- Discuss the role of private listing agreements
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 0.5 CEUs.
CCCEP File Number: 1066-2022-3381-I-P.
#
of credits: 0.5
Duration: 20 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
20 min
Duration
Pharmacy
Profession
0.5
# of credits
Learning Objectives
After viewing this expert brief, participants will be better able to:
- Describe how pharmacoeconomics is used to make listing decisions at the hospital /institutional level
- Explain how cost-effectiveness thresholds inform drug policy listing decisions
- Discuss the role of private listing agreements
CCCEP
Accredited
Course
CCCEP
ACCREDITATION
Medication, Medication Management
Learning Category
Medication
Topic
0
Price
2024-03-10
Expiry Date
CAN-eng
Region/Language
Course Description
Pharmacoeconomics have been used in various ways, including at the institutional level and for formulary decision-making around specialty pharmaceuticals. This program reviews the role of pharmacoeconomics and cost-effectiveness thresholds, along with mechanisms that influence and affect drug policy listing decisions.
This program is supported by Pharmascience
Faculty
Ahmad Abulaban, MBBS, SBN, CRND, MSCS, ABCN (CCEEG)
Assistant Professor of Neurology
King Saud bin-Abdulaziz University for Health Sciences
Neurology Consultant
Division of Neurology, Department of Medicine
King Abdulaziz Medical City, National Guard Health Affairs
Yaser M. Al Malik, MD, FRCPC, American Board of Psychiatry and Neurology, CSCN (EEG & EMG)
Assistant professor and Consultant Neurologist
King Saud bin Abdulaziz University for Health Sciences
King Abdulaziz Medical City, Ministry of National Guard Health Affairs
Moe Abdallah, B.SC., B.SC.PHM., R.PH
Clinical pharmacist, Drug Programs Policy and Strategy Branch
Ontario Public Drug Programs
Ministry of Health and Long-Term Care
Michael Boivin, RPh, BScPhm
Clinical Pharmacist Consultant and Continuing Education Developer
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 0.5 CEUs.
CCCEP File Number: 1066-2022-3381-I-P.
20 min
Duration
0
Price
0.5
# of credits
